| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |